Hypoxia protects human lung microvascular endothelial and epithelial-like cells against oxygen toxicity: Role of phosphatidylinositol 3-kinase

American Journal of Respiratory Cell and Molecular Biology

Volumn 28, Issue 2, 2003, Pages 179-187

  Ahmad, Shama ^a   Ahmad, Aftab ^a   Gerasimovskaya, Evgenia ^a   Stenmark, Kurt R ^a   Allen, Corrie B ^a   White, Carl W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; SEROTONIN; WORTMANNIN;

ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; LUNG ALVEOLUS CELL TYPE 2; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; MOLECULAR MECHANICS; OXYGEN TOXICITY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL DIVISION; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; HUMANS; LUNG; OXYGEN; SEROTONIN;

EID: 0037309949     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0004OC     Document Type: Article

References (50)

1. Jobe, A. H., and E. Bancalari. 2001. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163:1723-1729.
2. Jobe, A. J. 1999. The new BPD: an arrest of lung development. Pediatr. Res. 46:614-643.
3. Coalson, J. J., V. T. Winter, T. Siler-Khodr, and B. A. Yoder. 1999. Neonatal chronic lung disease in extremely immature baboons. Am. J. Respir. Crit. Care Med. 160:1333-1346.
4. Crapo, J. D., B. E. Barry, H. A. Foscue, and J. Shelburne. 1980. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122:123-143.
5. Mantell, L. L., and P. J. Lee. 2000. Signal transduction pathways in hyperoxia-induced lung cell death. Mol. Genet. Metab. 71:359-370.
6. Phillips, P. G., L. M. Birnby, and A. Narendran. 1995. Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells. Am. J. Physiol. 268:L789-L800.
7. Berra, E., J. Milanini, D. E. Richard, M, Le Gall, F. Vinals, E. Gothie, D. Roux, G. Pages, and J. Pouyssegur. 2000. Signaling angiogenesis via p42/ p44 MAP kinase and hypoxia. Biochem. Pharmacol. 60:1171-1178.
8. White, C. W., J. H. Jackson, I. F. McMurtry, and J. E. Repine. 1988. Hypoxia increases glutathione redox cycle and protects rat lungs against oxidants. J. Appl. Physiol. 65:2607-2616.
9. Allen, C. B., X. L. Guo, and C. W. White. 1998. Changes in pulmonary expression of hexokinase and glucose transporter mRNAs in rats adapted to hyperoxia. Am. J. Physiol. 274:L320-L329.
10. Allen, C. B., and C. W. White. 1998. Glucose modulates cell death due to normobaric hyperoxia by maintaining cellular ATP. Am. J. Physiol. 274:L159-L164.
11. Ahmad, A., S. Ahmad, B. K. Schneider, C. B. Allen, L.-Y. Chang, and C. W. White. 2002. Elevated expression of hexokinase-II protects human lung epithelial-like A549 cells against oxidative injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L573-L584.
12. Riddle, S. R., A. Ahmad, S. Ahmad, S. S. Deeb, M. Malkki, B. K. Schneider, C. B. Allen, and C. W. White. 2000. Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L407-L416.
13. Toker, A., and L. C. Cantley. 1997. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676.
14. Toker, A., and A. C. Newton. 2000. Cellular signaling: pivoting around PDK-1. Cell 103:185-188.
15. Toker, A. 2000. Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol. 57:652-658.
16. Page, K., J. Li, Y. Wang, S. Kartha, R. G. Pestell, and M. B. Hershenson. 2000. Regulation of cyclin D(1) expression and DNA synthesis by phosphatidylinositol 3-kinase in airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 23:436-443.
17. 2: regulation of reactive oxygen species levels by phosphatidyl inositol 3-kinase. J. Biol. Chem. 276:46379-46385.
18. Allen, C. B., B. K. Schneider, and C. W. White. 2001. Limitations to oxygen diffusion and equilibration in in vitro cell exposure systems in hyperoxia and hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1021-L1027.
19. Ward, S. G. 2000. Measurement of phosphoinositide 3-kinase activity. Methods Mol. Biol. 138:163-172.
20. Khwaja, A., P. Rodriguez-Viciana, S. Wennstrom, P. H. Warne, and J. Downward. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:2783-2793.
21. Ahmad, S., C. W. White, L. Y. Chang, B. K. Schneider, and C. B. Allen. 2001. Glutamine protects mitochondrial structure and function in oxygen toxicity. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L779-L791.
22. Lee, S. L., and B. L. Fanburg. 1987. Glycolytic activity and enhancement of serotonin uptake by endothelial cells exposed to hypoxia/anoxia. Circ. Res. 60:653-658.
23. SAS Institute. 2000. JMP User's Guide, Version 4. SAS Institute, Cary, NC. pp. 1-281. 2001 Updated version JMP New Features, Version 4.0.4. SAS Institute, Cary, NC, pp. 1-42.
24. SAS Institute. 2000. JMP User's Guide, Version 4. SAS Institute, Cary, NC. pp. 1-281. 2001 Updated version JMP New Features, Version 4.0.4. SAS Institute, Cary, NC, pp. 1-42.
25. 2 toxicity by preexposure to hypoxia: lung antioxidant enzyme role. J. Appl. Physiol. 53:475-482.
26. Sjostrom, K., and J. D. Crapo. 1983. Structural and biochemical adaptive changes in rat lungs after exposure to hypoxia. Lab. Invest. 48:68-79.
27. Steinberg, H., D. J. Bassett, and A. B. Fisher. 1975. Depression of pulmonary 5-hydroxytryptamine uptake by metabolic inhibitors. Am. J. Physiol. 228:1298-1303.
28. Sheridan, N. P., and E. R. Block. 1988. Serotonin transport and fluidity in plasma membrane vesicles: effect of hyperoxia. Am. J. Physiol. 254:C781-C787.
29. Allen, M. C., and S. J. Watt. 1993. Effect of hyperbaric and normobaric oxygen on pulmonary endothelial cell function. Undersea Hyperb. Med. 20:39-48.
30. Cohen, Z., I. Bouchelet, A. Olivier, J. G. Villemure, R. Ball, D. B. Stanimirovic, and E. Hamel. 1999. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J. Cereb. Blood Flow Metab. 19:908-917.
31. Jackson, R. M., H. S. Ann, and S. Oparil. 1988. Hypoxia-induced oxygen tolerance: maintenance of endothelial metabolic function. Exp. Lung Res. 14:887-896.
32. Alvarez-Tejado, M., S. Naranjo-Suarez, C. Jimenez, A. C. Carrera, M. O. Landazuri, and L. del Peso. 2001. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem. 276:22368-22374.
33. Lu, Y., L. Parkyn, L. E. Otterbein, Y. Kureishi, K. Walsh, A. Ray, and P. Ray. 2001. Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J. Exp. Med. 193:545-549.
34. Gottlob, K., N. Majewsky, S. Kennedy, E. Kandel, R. B. Robey, and N. Hay. 2001. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes & Development: 1406-1418.
35. Mazure, N. M., E. Y. Chen, K. R. Laderoute, and A. J. Giaccia. 1997. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90:3322-3331.
36. Zundel, W., C. Schindler, D. Haas-Kogan, A. Koong, F. Kaper, E. Chen, A. R. Gottschalk, H. E. Ryan, R. S. Johnson, A. B. Jefferson, D. Stokoe, and A. J. Giaccia. 2000. Loss of PTEN facilitates H1F-1-mediated gene expression. Genes Dev. 14:391-396.
37. Aki, T., Y. Mizukami, Y. Oka, K. Yamaguchi, K. Uemura, T. Fujimiya, and K. Yoshida. 2001. Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. Biochem. J. 358:481-487.
38. Malhotra, R., and F. C. Brosius III. 1999. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J. Biol. Chem. 274:12567-12575.
39. Jiang, B. H., G. Jiang, J. Z. Zheng, Z. Lu, T. Hunter, and P. K. Vogt. 2001. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12:363-369.
40. Zhong, H., K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M. M. Georgescu, J. W. Simons, and G. L. Semenza. 2000. Modulation of hypoxiainducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60: 1541-1545.
41. Ebert, B. L., J. D. Firth, and P. J. Ratcliffe. 1995. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J. Biol. Chem. 270: 29083-29089.
42. Firth, J. D., B. L. Ebert, and P. J. Ratcliffe. 1995. Hypoxic regulation of lactate dehdrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270:21021-21027.
43. Semenza, G. L., P. H. Roth, H. M. Fang, and G. L. Wang. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757-23763.
44. Zaman, K., H. Ryu, D. Hall, K. O'Donovan, K. I. Lin, M. P. Miller, J. C. Marquis, J. M. Baraban, G. L. Semenza, and R. R. Ratan. 1999. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxiainducible factor-1 and ATF-1/CREB and increased expression of glycolyric enzymes, p21 (waf1/cip1), and erythropoietin. J. Neurosci. 19:9821-9830.
45. Forsythe, J. A., B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, and G. L. Semenza. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
46. Monick, M. M., A. B. Carter, P. K. Robeff, D. M. Flaherty, M. W. Peterson, and G. W. Hunninghake. 2001. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J. Immunol. 166:4713-4720.
47. Monick, M. M., R. K. Mallampalli, A. B. Carter, D. M. Flaherty, D. McCoy, P. K. Robeff, M. W. Peterson, and G. W. Hunninghake. 2001. Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and akt activity in human alveolar macrophages. J. Immunol. 167:5977-5985.
48. Madge, L. A., and J. S. Pober. 2000. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J. Biol. Chem. 275:15458-15465.
49. Narula, P., J. Xu, J. A. Kazzaz, C. G. Robbins, J. M. Davis, and S. Horowitz. 1998. Synergistic cytotoxicity from nitric oxide and hyperoxia in cultured lung cells. Am. J. Physiol. 274:L411-L416.
50. Jyonouchi. H., S. Sun, T. Abiru, S. Chareancholvanich, and D. H. Ingbar. 1998. The effects of hyperoxic injury and antioxidant vitamins on death and proliferation of human small airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 19:426-436.